Agreement in Principle With the Main Banking Partners of ORPEA S.A. Relating to an Additional Financing and the Adjustment of the Financing Documentation of June 2022
08 März 2023 - 08:00AM
Business Wire
Regulatory News:
Further to the press release of 6 March 2023 of ORPEA S.A.
(Paris:ORP), the Company continued its discussions with its main
banking partners, which has enabled to set the terms of the
agreement in principle, detailed below.
This agreement in principle is a major step in the
implementation of the group's financial restructuring in view of
the opening of an accelerated safeguard procedure in the course of
March.
It will allow, subject to obtaining the agreement of the credit
committees of the institutions concerned and the finalization of
the contractual documentation, to satisfy one of the conditions
precedent of the lock-up agreement relating to the financial
restructuring of the Company concluded on 14 February 2023 with, on
the one hand, the group of long-term investors led by the Caisse
des Dépôts et Consignations, including CNP Assurances, MAIF and
MACSF, and on the other hand, five institutions holding unsecured
debt of ORPEA S.A.
This agreement in principle is exclusively part of the
restructuring plan proposed by the Company, intended for the group
of investors led by the Caisse des Dépôts et Consignations to
become the controlling shareholder of the Company.
1. Additional financing via a secured syndicated loan of 600
million euros
Pursuant to the agreement in principle, an additional financing
via a secured syndicated loan in the amount of 600 million euros
will be made available by lenders including the main banking
partners with whom the Company had implemented the June 2022
financing.
This additional secured financing will be made available to
Niort 94 and Niort 95, which will hold part of the group's real
estate assets.
The implementation of this additional financing should notably
enable the group to cover its liquidity needs until the completion
of the capital increases.
This additional financing will include the provision of the
following credit facilities:
(i) A revolving credit facility, in the amount of 400 million
euros, maturing on 30 June 2026;
(ii) Two credit facilities, for a total amount of 200 million
euros, maturing on the earliest of the following dates: 31 December
2023 or 5 business days following the completion of all the capital
increases.
These credit facilities will bear interest at a rate equal to
EURIBOR, plus a margin of 2.00%.
The drawing of these credits will be subject to usual conditions
precedent for this type of financing and will also be conditional
on the completion of certain stages of the financial restructuring
of the Company (including approvals of competent authorities).
The other characteristics of this additional financing will be
communicated to the market once the contractual documentation will
have been finalised.
2. Adjustment of the documentation of the existing
financing
The main changes will be as follows:
- Margin reduced to 2.00% per year;
- Final maturity date extended to 31 December 2027;
- Contractual instalments as follows:
- 31 December 2023: 200 million euros
instalment
- 31 October 2024: 200 million euros
instalment
- 31 October 2025: 200 million euros
instalment (increased by the amount of the net proceeds of any
asset sale, up to 100 million euros)
- 31 October 2026: 200 million euros
instalment
- Commitment to dispose of real estate assets for €1.25 billion
(gross value, excluding duties) by 31 December 2025;
- 75% of the net proceeds from asset disposals, allocated to
mandatory prepayment, net of contractual instalments, subject to
maintaining a minimum liquidity of 300 million euros.
About ORPEA
ORPEA is a leading global player, expert in the care of all
types of frailty. The Group operates in 22 countries and covers
three core businesses: care for the elderly (nursing homes,
assisted living, home care), post-acute and rehabilitation care and
mental health care (specialized clinics). It has more than 72,000
employees and welcomes more than 255,000 patients and residents
each year.
https://www.orpea-group.com/
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a
member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and
CAC Mid 60 indices.
Warning - Forward-looking information
This press release contains forward-looking information that
involve risks and uncertainties, concerning the Group's expected
growth and profitability in the future which may significantly
impact the expected performance indicated in the forward-looking
statements. These risks and uncertainties are linked to factors out
of the control of the Company and not precisely estimated, such as
future market conditions. Any forward-looking statements made in
this press release are statements about the Company’s expectations
about a future situation and should be evaluated as such. Further
events or actual results may differ from those described in this
press release due to a number of risks and uncertainties that are
described in the 2021 Company’s Universal Registration Document
available on the Company’s website and on the Autorité des Marchés
Financiers website (www.amf-france.org), and in the Half-Year 2022
financial report which is available on the Company’s website.
This press release is for information purposes only and does not
constitute an offer to sell or a solicitation of an offer to buy
any securities in any jurisdiction
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230307006095/en/
Investor Relations ORPEA Benoit Lesieur Investor
Relations Director b.lesieur@orpea.net
Toll free tel. nb. for shareholders: +33 (0) 805 480
480
Investor Relations NewCap Dusan Oresansky Tel.:
+33 (0)1 44 71 94 94 ORPEA@newcap.eu
Media Relations ORPEA Isabelle Herrier-Naufle
Media Relations Director Tel.: +33 (0)7 70 29 53 74
i.herrier-naufle@orpea.net
Image 7
Charlotte Le Barbier Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr
Laurence Heilbronn Tel.: +33 (0)6 89 87 61 37 lheilbronn@image7.fr
Orpea (EU:ORP)
Historical Stock Chart
Von Aug 2023 bis Sep 2023
Orpea (EU:ORP)
Historical Stock Chart
Von Sep 2022 bis Sep 2023